PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
4.09%
Some net income increase while MRVL is negative at -213.26%. John Neff would see a short-term edge over the struggling competitor.
12.15%
Less D&A growth vs. MRVL's 90.01%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-1300.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
14.86%
SBC growth well above MRVL's 23.05%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-109.18%
Negative yoy working capital usage while MRVL is 45.72%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-320.21%
Both yoy AR lines negative, with MRVL at -57.27%. Martin Whitman would suspect an overall sector lean approach or softer demand.
7.33%
Some inventory rise while MRVL is negative at -421.08%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
72.73%
Lower AP growth vs. MRVL's 201.14%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-75.90%
Negative yoy usage while MRVL is 87.81%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-517.86%
Negative yoy while MRVL is 323.19%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-17.54%
Negative yoy CFO while MRVL is 1718.03%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-34.76%
Both yoy lines negative, with MRVL at -42.37%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-50.00%
Negative yoy acquisition while MRVL stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
38.29%
Purchases growth of 38.29% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
51.41%
Liquidation growth of 51.41% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
730.77%
We have some outflow growth while MRVL is negative at -737.81%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
173.44%
Investing outflow well above MRVL's 98.94%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-1.75%
Negative yoy issuance while MRVL is 7150.82%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-100.68%
We cut yoy buybacks while MRVL is 41.26%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.